Image de couverture de livre

MFN2 suppresses the accumulation of lipid droplets and the progression of clear cell renal cell carcinoma

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Zhiduan Cai, Wenjun Luo, Haoran Wang, Rui Zhu, Yaoji Yuan, Xiangyu Zhan, Mengyuan Xie, Haoquan Zhuang, Haoyu Chen, Yuyu Xu, Xiezhao Li, Leyuan Liu, Guibin Xu
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Cancer Science
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Identification of metabolic dysregulation and biomarkers for clear cell renal cell carcinoma
par: Bin Zheng, et autres
Publié: (2024)

CLEC18A interacts with sulfated glycosaminoglycans and controls clear cell renal cell carcinoma progression
par: Gustav Jonsson, et autres
Publié: (2025)

Acanthosis Nigricans associated with clear-cell renal cell carcinoma
par: Fernando Peixoto Ferraz de Campos
Publié: (2016)

Synchronous clear cell renal cell carcinoma and classic Hodgkin lymphoma
par: Phuoc Christie‐Nguyen, et autres
Publié: (2025)

Belzutifan's role in the treatment landscape of clear cell renal cell carcinoma
par: Adrienne H. Chen, et autres
Publié: (2025)

Tumor‐associated macrophages impair NK cell IFN‐γ production and contribute to tumor progression in clear cell renal cell carcinoma
par: Sol Yanel Núñez, et autres
Publié: (2024)

Differences in mutations across tumour sizes in clear‐cell renal cell carcinoma
par: Steven M. Monda, et autres
Publié: (2024)

Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma
par: Wenhao Xu, et autres
Publié: (2024)

Integrative analysis of bulk and single‐cell RNA sequencing reveals sphingolipid metabolism and immune landscape in clear cell renal cell carcinoma
par: Dongdong Xie, et autres
Publié: (2024)

CD2AP is a potential prognostic biomarker of renal clear cell carcinoma
par: Can Chen, et autres
Publié: (2024)

Paraoxonase‐2 shRNA‐mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines
par: Valentina Schiavoni, et autres
Publié: (2024)

Comprehensive analysis of pain genes in prognosis of kidney renal clear cell carcinoma and tumor immunotherapy: A comprehensive bioinformatic study
par: Xiao‐Yu Zhuang, et autres
Publié: (2024)

Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor
par: Georges Gebrael, et autres
Publié: (2024)

A multimodal deep learning framework for predicting sunitinib response in advanced clear cell renal cell carcinoma
par: Xi Tian, et autres
Publié: (2025)

A multimodal ensemble approach for clear cell renal cell carcinoma treatment outcome prediction
par: Chen, Meixu, et autres
Publié: (2024)

Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma
par: Motohiro Fujiwara, et autres
Publié: (2024)

CPA4 as a biomarker promotes the proliferation, migration and metastasis of clear cell renal cell carcinoma cells
par: Kongjia Wang, et autres
Publié: (2024)

CRYAB is upregulated and predicts clinical prognosis in kidney renal clear cell carcinoma
par: Hao Ren, et autres
Publié: (2025)

Diagnostic, predictive and prognostic molecular biomarkers in clear cell renal cell carcinoma: A retrospective study
par: Jian Deng, et autres
Publié: (2024)

Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade
par: Frederik F. Thomsen, et autres
Publié: (2024)

Volumetric imaging of the tumor microvasculature reflects outcomes and genomic states of clear cell renal cell carcinoma
par: Yuta Kaneko, et autres
Publié: (2024)

Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma
par: Martyna Parol‐Kulczyk, et autres
Publié: (2024)

Single‐cell transcriptomic analysis in clear cell renal cell carcinoma: Deciphering the role of APP within the tumour microenvironment
par: Bo Guan, et autres
Publié: (2024)

Unravelling infiltrating T‐cell heterogeneity in kidney renal clear cell carcinoma: Integrative single‐cell and spatial transcriptomic profiling
par: Haiqing Chen, et autres
Publié: (2024)

Comprehensive analysis of m6A methylome and transcriptome by Nanopore sequencing in clear cell renal carcinoma
par: Hexin Li, et autres
Publié: (2024)

Comprehensive analyses of nuclear mitochondria‐related genes in the molecular features, immune infiltration, and drug sensitivity of clear cell renal cell carcinoma
par: Yuchen Zhang, et autres
Publié: (2024)

Exosome‐related lncRNA score: A value‐based individual treatment strategy for predicting the response to immunotherapy in clear cell renal cell carcinoma
par: Zhan Yang, et autres
Publié: (2024)

METTL14‐mediated m6A modification of ZFP14 inhibits clear cell renal cell carcinoma progression via promoting STAT3 ubiquitination
par: Zhuonan Liu, et autres
Publié: (2025)

Diagnostic value of imaging in patients with clear cell papillary renal cell carcinoma: A case series and literature review
par: Yuxuan Song, et autres
Publié: (2024)

Carbonic anhydrase‐9‐targeted near‐infrared photoimmunotherapy as a theranostic modality for clear cell renal cell carcinoma
par: Hiroshi Fukushima, et autres
Publié: (2025)

Tissue Memory Score: a transcriptomic biomarker of proximal tubular dedifferentiation independently prognostic in clear cell renal cell carcinoma
par: khalil, Somar, et autres
Publié: (2026)

Multi‐instance learning for identifying high‐risk subregions associated with synchronous distant metastasis in clear cell renal cell carcinoma
par: Ling‐Feng Xue, et autres
Publié: (2024)

Overexpression of m 7 G writers METTL1 and BUD23 confers oncogenicity in kidney renal clear cell carcinoma
par: Anni Su, et autres
Publié: (2025)

Troponin T1 in tumorigenesis and immune modulation: Insights into multiple cancers and kidney renal clear cell carcinoma
par: Qianjin Zhang, et autres
Publié: (2024)

Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma
par: Anna Brännbäck, et autres
Publié: (2025)

Unravelling the distinct effects of VHL mutations and chromosome 3p loss in clear cell renal cell carcinoma: Implications for prognosis and treatment
par: Xiang Wang, et autres
Publié: (2025)

Proteomic profiling of ovarian clear cell carcinomas identifies prognostic biomarkers for chemotherapy
par: Liang Yue, et autres
Publié: (2024)

liangwei01/Sample-specific network analysis identifies gene co-expression patterns of immunotherapy response in clear cell renal cell carcinoma
par: Liangwei Yin (尹良威)
Publié: (2025)

Cinematic rendering of 18 F‐DCFPyL PET/CT fusion data in a patient with metastatic clear cell renal cell carcinoma
par: Steven P. Rowe, et autres
Publié: (2024)

Real‐world comparison of cabozantinib and sunitinib in advanced non‐clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group
par: Gökhan Şahin, et autres
Publié: (2025)